These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 6992001)

  • 41. Osteocalcin in serum, saliva and gingival crevicular fluid: their relation with periodontal treatment outcome in postmenopausal women.
    Bullon P; Chandler L; Segura Egea JJ; Perez Cano R; Martinez Sahuquillo A
    Med Oral Patol Oral Cir Bucal; 2007 May; 12(3):E193-7. PubMed ID: 17468712
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Monitoring periodontal disease status in smokers and nonsmokers using a gingival crevicular fluid matrix metalloproteinase-8-specific chair-side test.
    Mäntylä P; Stenman M; Kinane D; Salo T; Suomalainen K; Tikanoja S; Sorsa T
    J Periodontal Res; 2006 Dec; 41(6):503-12. PubMed ID: 17076774
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evaluation of t-PA, PAI-2, IL-1beta and PGE(2) in gingival crevicular fluid of rheumatoid arthritis patients with periodontal disease.
    Biyikoğlu B; Buduneli N; Kardeşler L; Aksu K; Oder G; Kütükçüler N
    J Clin Periodontol; 2006 Sep; 33(9):605-11. PubMed ID: 16856901
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Periodontal disease monitoring.
    Bader H
    Dent Today; 1997 Mar; 16(3):52-4. PubMed ID: 9560639
    [No Abstract]   [Full Text] [Related]  

  • 45. Adjunctive periodontal therapies.
    Wang IC; Roberts FA
    Pract Proced Aesthet Dent; 2005 May; 17(4):245-6. PubMed ID: 16075498
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Gingival inflammation, increased periodontal pocket depth and elevated interleukin-6 in gingival crevicular fluid of depressed women on long-term sick leave.
    Johannsen A; Rydmark I; Söder B; Asberg M
    J Periodontal Res; 2007 Dec; 42(6):546-52. PubMed ID: 17956468
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Glucose as an indicator of periodontal disease.
    Huggins HA
    N Y State Dent J; 1981 Oct; 47(8):466-70. PubMed ID: 7027105
    [No Abstract]   [Full Text] [Related]  

  • 48. Gingival crevicular fluid interleukin-1beta, prostaglandin E2 and periodontal status in a community population.
    Zhong Y; Slade GD; Beck JD; Offenbacher S
    J Clin Periodontol; 2007 Apr; 34(4):285-93. PubMed ID: 17378884
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Bone resorbing activity and cytokine levels in gingival crevicular fluid before and after treatment of periodontal disease.
    Holmlund A; Hänström L; Lerner UH
    J Clin Periodontol; 2004 Jun; 31(6):475-82. PubMed ID: 15142219
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical examination and interleukin-1beta levels in gingival crevicular fluid in patients treated with removable partial dentures.
    Kurtiş B; Tüter G; Korkmaz T; Yücel A; Serdar M; Ozcan G
    Int J Prosthodont; 2003; 16(1):59-63. PubMed ID: 12675457
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The gingival crevicular fluid ciprofloxacin level in subjects with gingivitis and periodontitis, and its effects on clinical parameters.
    Tezel A; Yucel O; Orbak R; Kara C; Kavrut F; Yagiz H; Sahin T
    J Periodontal Res; 2005 Oct; 40(5):395-400. PubMed ID: 16105092
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Gingival crevicular fluid transforming growth factor-beta1 in several forms of periodontal disease.
    Gürkan A; Emingil G; Cinarcik S; Berdeli A
    Arch Oral Biol; 2006 Oct; 51(10):906-12. PubMed ID: 16787634
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [The tetracycline cyclohexylsulfamate in dentistry].
    Carlier C
    Rev Stomatoodontol Nord Fr; 1969; 24(94):109-11. PubMed ID: 5800815
    [No Abstract]   [Full Text] [Related]  

  • 54. Periodontal treatment by local drug delivery using resorbable base material.
    Noguchi T; Fukuda M; Ishikawa I
    Adv Dent Res; 1988 Nov; 2(2):401-4. PubMed ID: 3271038
    [No Abstract]   [Full Text] [Related]  

  • 55. [Experiences with Placentadent in the treatment of gingival and periodontal diseases].
    Stroh F
    Kassenzahnarzt Colloq Med Dent; 1965 Nov; 28():13-4. PubMed ID: 5216821
    [No Abstract]   [Full Text] [Related]  

  • 56. [Materials relevant to the prevention and treatment of gingival and periodontal lesions].
    Caffesse RG; Caride ER; Carraro JJ
    Fauchard; 1970 Mar; 1(3):134-5 passim. PubMed ID: 5274687
    [No Abstract]   [Full Text] [Related]  

  • 57. Tetracycline.
    N Y J Dent; 1980; 50(6):229. PubMed ID: 6992001
    [No Abstract]   [Full Text] [Related]  

  • 58. Treating periodontal diseases by blocking tissue-destructive enzymes.
    Golub LM; Wolff M; Roberts S; Lee HM; Leung M; Payonk GS
    J Am Dent Assoc; 1994 Feb; 125(2):163-9; discussion 169-71. PubMed ID: 8113524
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Use of tetracycline in periodontal therapy].
    Höcker K
    Quintessenz; 1986 May; 37(5):881-5. PubMed ID: 3462792
    [No Abstract]   [Full Text] [Related]  

  • 60. Local antimicrobial therapies in periodontal disease.
    Kinane DF
    Ann R Australas Coll Dent Surg; 2000 Oct; 15():57-60. PubMed ID: 11709978
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.